These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis. Akbari M; Tabrizi R; Kardeh S; Lankarani KB PLoS One; 2019; 14(7):e0219865. PubMed ID: 31348819 [TBL] [Abstract][Full Text] [Related]
3. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow-up multicenter study. González CA; Sanz-Anquela JM; Companioni O; Bonet C; Berdasco M; López C; Mendoza J; Martín-Arranz MD; Rey E; Poves E; Espinosa L; Barrio J; Torres MÁ; Cuatrecasas M; Elizalde I; Bujanda L; Garmendia M; Ferrández Á; Muñoz G; Andreu V; Paules MJ; Lario S; Ramírez MJ; ; Gisbert JP J Gastroenterol Hepatol; 2016 May; 31(5):953-8. PubMed ID: 26630310 [TBL] [Abstract][Full Text] [Related]
4. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075 [TBL] [Abstract][Full Text] [Related]
5. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer. Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697 [TBL] [Abstract][Full Text] [Related]
6. Follow-up of premalignant lesions in patients at risk for progression to gastric cancer. den Hoed CM; Holster IL; Capelle LG; de Vries AC; den Hartog B; Ter Borg F; Biermann K; Kuipers EJ Endoscopy; 2013; 45(4):249-56. PubMed ID: 23533073 [TBL] [Abstract][Full Text] [Related]
7. [Precancerous conditions in gastric cancer (II): relationship between atrophic gastritis-intestinal metaplasia-gastric dysplasia-gastric carcinoma]. Martínez Díaz FJ; Canteras Jordana M; Ortuño Pacheco G Rev Esp Enferm Dig; 1991 Jul; 80(1):17-21. PubMed ID: 1931240 [TBL] [Abstract][Full Text] [Related]
8. Increased Risk of Progression to Gastric Adenocarcinoma in Patients with Non-dysplastic Gastric Intestinal Metaplasia Versus a Control Population. Dhingra R; Natov NS; Daaboul Y; Guelrud M; Cherukara A; Hung PF; Sterling MJ Dig Dis Sci; 2020 Nov; 65(11):3316-3323. PubMed ID: 31916085 [TBL] [Abstract][Full Text] [Related]
9. Adequacy of endoscopic recognition and surveillance of gastric intestinal metaplasia and atrophic gastritis: A multicentre retrospective study in low incidence countries. Honing J; Keith Tan W; Dieninyte E; O'Donovan M; Brosens L; Weusten B; di Pietro M PLoS One; 2023; 18(6):e0287587. PubMed ID: 37352223 [TBL] [Abstract][Full Text] [Related]
10. Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study. Capelle LG; den Hoed CM; de Vries AC; Biermann K; Casparie MK; Meijer GA; Kuipers EJ Eur J Gastroenterol Hepatol; 2012 Jan; 24(1):42-7. PubMed ID: 22081006 [TBL] [Abstract][Full Text] [Related]
11. Occurrence of gastric cancer in patients with atrophic gastritis during long-term follow-up. Zhang L; Liu Y; You P; Feng G Scand J Gastroenterol; 2018; 53(7):843-848. PubMed ID: 29911441 [TBL] [Abstract][Full Text] [Related]
12. Outcome of intestinal metaplasia in gastric biopsy of patients with dyspepsia in Guilan Province, North Iran. Mansour-Ghanaei F; Joukar F; Soati F; Mansour-Ghanaei A; Atrkar-Roushan Z Asian Pac J Cancer Prev; 2013; 14(6):3549-54. PubMed ID: 23886143 [TBL] [Abstract][Full Text] [Related]
13. Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Chen HN; Wang Z; Li X; Zhou ZG Gastric Cancer; 2016 Jan; 19(1):166-75. PubMed ID: 25609452 [TBL] [Abstract][Full Text] [Related]
14. Pseudopyloric Metaplasia Is Not Associated With the Development of Gastric Cancer. Dilaghi E; Baldaro F; Pilozzi E; Conti L; Palumbo A; Esposito G; Annibale B; Lahner E Am J Gastroenterol; 2021 Sep; 116(9):1859-1867. PubMed ID: 34313623 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area. Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802 [TBL] [Abstract][Full Text] [Related]
16. Gastric cancer occurrence in preneoplastic lesions: a long-term follow-up in a high-risk area in Spain. González CA; Pardo ML; Liso JM; Alonso P; Bonet C; Garcia RM; Sala N; Capella G; Sanz-Anquela JM Int J Cancer; 2010 Dec; 127(11):2654-60. PubMed ID: 20178099 [TBL] [Abstract][Full Text] [Related]
17. Intestinal metaplasia surveillance: searching for the road-map. Zullo A; Hassan C; Repici A; Annibale B World J Gastroenterol; 2013 Mar; 19(10):1523-6. PubMed ID: 23539645 [TBL] [Abstract][Full Text] [Related]
18. The Incidence of Gastric Adenocarcinoma Among Patients With Gastric Intestinal Metaplasia: A Long-term Cohort Study. Lee TY; Wang RC; Lee YC; Lin JT; Ho HJ; Hsieh MC; Wu CY J Clin Gastroenterol; 2016 Aug; 50(7):532-7. PubMed ID: 26444645 [TBL] [Abstract][Full Text] [Related]
19. Histopathological phenotypes of early gastric cancer and its background mucosa. Kudo Y; Morohashi S; Takasugi K; Tsutsumi S; Ogasawara H; Hanabata N; Yoshimura T; Sato F; Fukuda S; Kijima H Biomed Res; 2011 Apr; 32(2):127-34. PubMed ID: 21551948 [TBL] [Abstract][Full Text] [Related]
20. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial). Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]